chlorpromazine has been researched along with allopurinol in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (20.83) | 18.7374 |
1990's | 14 (29.17) | 18.2507 |
2000's | 10 (20.83) | 29.6817 |
2010's | 14 (29.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Barr, JT; Jones, JP | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Huh, K; Iwata, H; Yamamoto, I | 1 |
Chatterjee, SN | 1 |
Belzer, FO; Kim, SK; Southard, JH | 1 |
Collins, GM; Esquivel, CO; Tokunaga, Y; Wicomb, WN | 1 |
Collins, GM; Concepcion, W; Esquivel, CO; Nakazato, P; Tokunaga, Y; Wicomb, WN | 1 |
Collins, GM; Concepcion, W; Cox, KL; Esquivel, CO; Nakazato, P; Tokunaga, Y; Wicomb, WN | 1 |
Ahrén, B; Ar'Rajab, A; Bengmark, S; Sundberg, R | 1 |
Ikai, I; Kamiyama, Y; Morimoto, T; Nakase, Y; Ozaki, N; Ozawa, K; Shimahara, Y; Tokunage, Y; Wakashiro, S; Yamaoka, Y | 1 |
Abe, K; Kogure, K; Sekizawa, T | 1 |
Barg, TsM | 1 |
Andrews, TM; Brown, E; Griffiths, MI; McKeran, RO; Watts, RW | 1 |
Campos, RA; Moberg, AW; Mozes, MF; Najarian, JS; Toledo-Pereyra, LH | 1 |
Najarian, JS; Simmons, RL; Toledo-Pereyra, LH | 1 |
Abdalla, DS; Bechara, EJ | 1 |
Andrzejewska, S; Arendarczyk, W; Druzyńska, J; Gembal, M; Wójcikowski, C | 1 |
Collins, GM; Concepcion, W; Egawa, H; Esquivel, CO; Keeffe, EB; Menegaux, F; So, SK | 1 |
Collins, GM; Egawa, H; Esquivel, CO; Kennedy, RG; Menegaux, F; Wicomb, WN | 1 |
Collins, GM; Egawa, H; Esquivel, CO; Kennedy, RG; Wicomb, WN | 1 |
Bry, WI; Collins, GM; Feduska, NJ; Salvatierra, O; Warren, R; Wicomb, WN; Wong, L | 1 |
Collins, G; Concepcion, W; Esquivel, C; Itasaka, H; Lim, J; Nakazato, PZ | 1 |
Burns, W; Collins, G; Esquivel, CO; Garcia-Kennedy, R; Hayashi, M; Tojimbara, T; Wicomb, WN | 1 |
Du Souich, P; El-Kadi, A; Haddad, P; Serrar, H | 1 |
Beedham, C; Brown, JE; Clarke, SE; Jordan, CG; Laljee, H; Rashidi, MR | 1 |
Ikeda, K; Kawaguchi, Y; Masuda, H; Matsushima, E; Nagayama, S; Yoshisue, K | 1 |
Bosman, GJ; Brock, R; Cluitmans, JC; Favretto, ME | 1 |
3 review(s) available for chlorpromazine and allopurinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic agents of potential value in protecting kidneys from ischemic damage.
Topics: Adrenal Cortex Hormones; Allopurinol; Animals; Chlorpromazine; Dogs; Glutathione; Humans; Ischemia; Kidney; Kidney Transplantation; Magnesium Sulfate; Malonates; Organ Preservation; Oxamic Acid; Phenoxybenzamine; Rats; Tissue Preservation | 1977 |
[Eye complications during use of various medicinal substances with general effects (review of the literature)].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Bacterial Agents; Antimalarials; Cardiac Glycosides; Cataract; Child; Chloroquine; Chlorpromazine; Epinephrine; Ethambutol; Ethchlorvynol; Eye Diseases; Female; Humans; Miotics; Nalidixic Acid; Phosphates; Pilocarpine; Quinolines; Retinal Degeneration; Warfarin | 1969 |
3 trial(s) available for chlorpromazine and allopurinol
Article | Year |
---|---|
Comparative effects of blood, colloid, and Ringer's lactate terminal allograft rinse on the results of orthotopic liver transplantation.
Topics: Adenosine; Allopurinol; Blood; Chlorpromazine; Colloids; Disaccharides; Female; Follow-Up Studies; Glutathione; Graft Survival; Humans; Insulin; Isotonic Solutions; Length of Stay; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Organ Preservation; Organ Preservation Solutions; Raffinose; Ringer's Lactate; Sucrose; Survival Analysis; Time Factors; Transplantation, Homologous | 1993 |
Canine and cadaver kidney preservation with sodium lactobionate sucrose solution.
Topics: Adenosine; Adult; Allopurinol; Animals; Cadaver; Chlorpromazine; Creatinine; Disaccharides; Dogs; Glutathione; Graft Survival; Humans; Hypertonic Solutions; Insulin; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Organ Preservation; Organ Preservation Solutions; Raffinose; Solutions; Sucrose; Time Factors; Tissue Donors | 1993 |
Effects of abdominal en bloc procurement and of a high sodium preservation solution in liver transplantation.
Topics: Actuarial Analysis; Adenosine; Adult; Allopurinol; Chlorpromazine; Disaccharides; Glutathione; Graft Survival; Humans; Insulin; Liver; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Pilot Projects; Raffinose; Retrospective Studies; Solutions; Sucrose; Survival Analysis | 1993 |
42 other study(ies) available for chlorpromazine and allopurinol
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase.
Topics: Aldehyde Oxidase; Aminoacridines; Chromatography, Liquid; Enzyme Inhibitors; Humans; Liver; Magnetic Resonance Spectroscopy; Mass Spectrometry; Oxidation-Reduction | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Hepatic allopurinol oxidizing enzyme in mice].
Topics: Aldehyde Oxidoreductases; Allopurinol; Animals; Chlorpromazine; Desipramine; Dexamethasone; Dialysis; Diphenhydramine; Hot Temperature; Imipramine; Ions; Liver; Male; Mice; Niacinamide; Oxypurinol; Testosterone; Time Factors; Vitamin K; Xanthine Oxidase | 1975 |
Loss of mitochondrial respiratory function and its suppression during cold ischemic preservation of rat livers with University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Animals; Chlorpromazine; Cryopreservation; Fatty Acids, Nonesterified; Glutathione; Insulin; Liver; Male; Mitochondria, Liver; Oligomycins; Organ Preservation; Organ Preservation Solutions; Oxygen Consumption; Raffinose; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; Solutions; Time Factors; Verapamil | 1992 |
Calcium antagonists in sodium lactobionate sucrose solution for rat liver preservation.
Topics: Adenosine; Allopurinol; Animals; Calcium; Calcium Channel Blockers; Chlorpromazine; Disaccharides; Glutathione; Insulin; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Strains; Solutions; Sucrose; Trifluoperazine | 1992 |
Successful 20-hour rat liver preservation with chlorpromazine in sodium lactobionate sucrose solution.
Topics: Adenosine; Allopurinol; Bile; Chlorpromazine; Disaccharides; Glutathione; Humans; Hydrogen-Ion Concentration; Insulin; L-Lactate Dehydrogenase; Liver; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Raffinose; Solutions; Sucrose; Time Factors | 1991 |
Improved rat liver preservation using chlorpromazine in a new sodium lactobionate sucrose solution.
Topics: Adenosine; Allopurinol; Animals; Chlorpromazine; Disaccharides; Glutathione; Insulin; L-Lactate Dehydrogenase; Liver; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Strains; Solutions; Sucrose; Trifluoperazine | 1991 |
Improvement of liver preservation quality with UW solution by chlorpromazine pretreatment of the donor in an experimental model.
Topics: Adenosine; Alanine Transaminase; Allopurinol; Animals; Bile; Chlorpromazine; Glutathione; Insulin; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Rabbits; Raffinose; Solutions; Time Factors | 1989 |
Evaluation of cytoprotective drugs for liver preservation by pyridine nucleotide fluorometry.
Topics: Allopurinol; Animals; Cell Membrane; Chlorpromazine; Dibucaine; Epoprostenol; Liver; Male; Mitochondria, Liver; Organ Preservation; Oxidation-Reduction; Phenoxybenzamine; Prostaglandins, Synthetic; Pyrimidine Nucleotides; Rats; Rats, Inbred Strains | 1988 |
Biphasic effects of chlorpromazine on cell viability in a neuroblastoma cell line.
Topics: Calcium; Cell Line; Cell Membrane Permeability; Cell Survival; Chlorpromazine; Humans; Lipid Peroxides; Neuroblastoma; Xanthine; Xanthine Oxidase; Xanthines | 1986 |
Clinical and biochemical studies on treatment of Lesch-Nyhan syndrome.
Topics: Adenine; Allopurinol; Body Weight; Child, Preschool; Chlorpromazine; Creatinine; Exchange Transfusion, Whole Blood; Humans; Language Development; Lesch-Nyhan Syndrome; Male; Motor Skills; Movement Disorders; Pedigree; Pentosyltransferases; Phenothiazines; Tetrabenazine; Uric Acid | 1974 |
Prevention of irreversible ischemic damage in renal preservation by pharmacological manipulation.
Topics: Allopurinol; Animals; Chlorpromazine; Dogs; Hypothermia; Ischemia; Kidney Transplantation; Methylprednisolone; Phenoxybenzamine; Tissue Preservation; Tissue Survival; Transplantation, Autologous | 1974 |
Comparative effects of chlorpromazine, methylprednisolone, and allopurinol during small bowel preservation.
Topics: Allopurinol; Animals; Chlorpromazine; Dogs; Injections, Intravenous; Intestine, Small; Ischemia; Methylprednisolone; Perfusion; Tissue Preservation; Tissue Survival; Transplantation, Homologous | 1973 |
The effect of chlorpromazine and Li2CO3 on the superoxide dismutase and glutathione peroxidase activities of rat brain, liver and erythrocytes.
Topics: Animals; Brain; Chlorpromazine; Erythrocytes; Glutathione Peroxidase; Lithium Carbonate; Liver; Male; Rats; Rats, Wistar; Superoxide Dismutase; Xanthine Oxidase | 1994 |
Protective effect of allopurinol, alpha-tocopherol and chlorpromazine on rat pancreatic islets stored prior to transplantation.
Topics: Allopurinol; Animals; Blood Glucose; Chlorpromazine; Graft Survival; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Rats; Rats, Wistar; Tissue Preservation; Vitamin E | 1993 |
Significance of terminal rinse for rat liver preservation.
Topics: Adenosine; Allopurinol; Animals; Chlorpromazine; Disaccharides; Glutathione; Insulin; Isotonic Solutions; Liver; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Ringer's Lactate; Sucrose; Time Factors | 1993 |
Significance of terminal rinse for rat liver preservation.
Topics: Adenosine; Allopurinol; Animals; Chlorpromazine; Disaccharides; Evaluation Studies as Topic; Glutathione; Graft Survival; Insulin; Liver; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Sucrose | 1993 |
Liver transplantation from non-heart beating donors in rats: influence of viscosity and temperature of initial flushing solutions on graft function.
Topics: Adenosine; Alanine Transaminase; Allopurinol; Animals; Chlorpromazine; Disaccharides; Glutathione; Graft Survival; Hydroxyethyl Starch Derivatives; Insulin; Isotonic Solutions; Lactic Acid; Liver; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Ringer's Solution; Solutions; Sucrose; Survival Rate; Temperature; Vascular Resistance; Viscosity | 1997 |
Cytochrome P-450 content and activity after cold storage of rat hepatocytes in university of wisconsin and sodium-lactobionate-sucrose solutions.
Topics: Adenosine; Allopurinol; Animals; Cell Survival; Chlorpromazine; Cryopreservation; Cytochrome P-450 Enzyme System; Disaccharides; Glutathione; Insulin; Liver; Male; Organ Preservation Solutions; Raffinose; Rats; Rats, Sprague-Dawley; Sucrose; Theophylline | 1999 |
Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man.
Topics: Acyclovir; Aldehyde Oxidase; Aldehyde Oxidoreductases; Allopurinol; Animals; Chlorpromazine; Enzyme Inhibitors; Guanine; Guinea Pigs; Humans; Kinetics; Liver; Methotrexate; Oxidation-Reduction; Rabbits; Species Specificity; Stereoisomerism; Substrate Specificity; Vitamin K | 1999 |
Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
Topics: Administration, Oral; Allopurinol; Animals; Antimetabolites, Antineoplastic; Area Under Curve; Biotransformation; Carbon Radioisotopes; Chlorpromazine; Drug Combinations; Drugs, Chinese Herbal; Fluorouracil; Glycyrrhiza; Intestine, Small; Male; Microsomes, Liver; Oxonic Acid; Paeonia; Pyridines; Rats; Rats, Inbred Strains; Sarcoma, Yoshida; Tegafur; Tissue Distribution; Triazines; Uracil; Xanthine Oxidase | 2000 |
Human erythrocytes as drug carriers: loading efficiency and side effects of hypotonic dialysis, chlorpromazine treatment and fusion with liposomes.
Topics: Antipsychotic Agents; beta-Galactosidase; Chlorpromazine; Dialysis; Drug Carriers; Erythrocytes; Fluorescent Dyes; Hemolysis; Horseradish Peroxidase; Humans; Hypotonic Solutions; Phosphatidylserines; Rhodamines; Xanthine Oxidase | 2013 |